Introduction
The association of repeated attacks of vertigo that last for hours with a sense of aural fullness, fluctuating progressive hearing loss and tinnitus is characteristic of endolymphatic hydrops. In most cases, it is impossible to determine an etiology and a diagnosis of idiopathic endolymphatic hydrops, or Ménière's disease, until it is established. The endolymphatic sac is thought to maintain the hydrostatic pressure and endolymphatic homeostasis for the inner ear and its dysfunction is thought to contribute to the pathophysiology of Mé niè re's disease.
Vertigo attributed to endolymphatic hydrops, whether idiopathic or secondary to a known etiology, is amenable to either medical or surgical treatment. Treatment is usually symptomatic with sedatives and antiemetics during the acute phase, and diuretics or vasodilators for chronic control. Steroids are also useful either when applied directly with transtympanic injections or systemically. The psychological support of these patients is also an important part of the treatment. Surgical treatment is usually offered when the conservative therapy has failed and the vertigo becomes incapacitating and untreatable by other means. The surgical options include labyrinthectomy, vestibular neurectomy, endolymphatic sac surgery and transtympanic gentamicin injections for a chemical labyrinthectomy. 1 However, the treatment options that appear to be most effective are those which are more invasive or that pose a greater risk for hearing loss. In this case, it is desirable to recommend a procedure that offers a high likelihood of vertigo control with maximum hearing preservation.
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Few surgical procedures in otology are as controversial as endolymphatic sac decompression. This surgical procedure offers the possibility of controlling vertigo with a minimal risk of morbidity by decreasing the amount of pressure in the endolymphatic space. A large number of authors think of it as safe and effective. The average success rate for vertigo control with this technique, considering different studies, is around 80%.
3 Because of the low rates of hearing loss associated with this procedure, it is considered a conservative treatment. However, there are some who question its long-term efficacy, and even those who think that the vertigo control achieved after surgery is more due to a placebo effect than because of the procedure itself. [4] [5] [6] Despite this controversy, many surgeons around the world still recommend the endolymphatic sac decompression.
Review of the Literature
The first surgical procedure for treating Mé niè re's disease was described in 1927 In 1981, Thomsen et al 4 performed a double-blind study, in which they treated patients with Mé niè re's disease either with endolymphatic sac decompression and shunting, or with a simple mastoidectomy as a control procedure. They could not observe any difference between the two groups. However, a significant reduction in symptoms was reported in both groups, and 70% of all patients were classified as successfull considering the criteria used at that time. The study concluded that the surgical procedure had no effect whatsoever in the resolution of symptoms from Mé niè re's disease and that its efficacy was produced by a placebo effect. The patients were reexamined 3 years after surgery, and it was still not possible to demonstrate any differences between the sham and the active surgery. Excellent results were observed and no complications or side effects were noted. The cost effectiveness of this officebased procedure was compared to that of endolymphatic sac decompression surgery, clearly in favor of dexamethasone perfusion. This procedure also offers other advantages over surgery, since it may be started immediately, even during acute episodes, being well tolerated and without the need of preoperative exams or evaluations. It may be used in hearing or non-hearing ears for patients whose systemic conditions are not amenable for a surgical intervention.
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In 2008, Kitahara et al 25 suggested an interesting treatment modality that combined both procedures. These authors performed endolymphatic sac decompression with intra-endolymphatic sac application of steroids as a new therapeutic strategy for intractable Mé niè re's disease. They divided their patients in three groups, one in which only endolymphatic sac decompression was performed, another in which endolymphatic sac decompression was accompanied by intra-endolymphatic sac application of steroids, and another control group, which did none of the above. They found that the intra-endolymphatic sac application of large doses of steroids had additional effects to those of endolymphatic sac-expanding surgery, especially on hearing, and that both of the treated groups were superior to the non-surgical treatment of intractable Mé niè re's disease, both for vertigo control and hearing improvement for at least 7 years. Another surgical procedure suggested to treat vertigo in patients with hard to control Mé niè re's disease is cochleosacculotomy, a surgical procedure performed through the round window to create a shunt between the cochlear duct and the saccule, with the objective of diminishing endolymphatic pressure. The problem with this procedure is that it damages hearing as well as vestibular functions. In different studies, its efficacy is compared to that of endolymphatic sac decompression. In 1991, Giddings patients who underwent cochleosacculotomy with 14 patients who had endolymphatic sac decompression surgery. Vertigo improved significantly in both groups but the hearing level was significantly impacted, especially in patients who had undergone cochleosacculotomy, speaking in favor of endolymphatic sac decompression. A novel surgical technique for the treatment of Mé niè re's disease was described recently, the endolymphatic duct blockage. In this technique, the sac is not incised or dissected from the posterior fossa dura. All the bone found around the endolymphatic duct is dissected in order to identify as much of the duct as possible, then the duct is blocked with two small titanium clips. 30 In 2015, Saliba et al 30 reported a nonblinded randomized controlled trial comparing this technique against traditional endolymphatic sac decompression and found that 96.5% of the patients in the endolymphatic blockage group had achieved a complete control of vertigo spells against 37.5% of the endolymphatic sac decompression group, with no significant difference between the preoperative and the postoperative hearing levels in both groups. Their study suggested that this novel technique might be better than endolymphatic sac decompression. In a followup study in 2016, with a larger group of patients, this same group reported a total absence of Mé niè re's attacks in 89.9% of the patients treated with this novel technique.
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The endolymphatic sac surgery keeps evolving, as it seems to be a universally accepted procedure for the treatment of difficult to control Mé niè re's disease, even though it is still controversial. In a 2014 anatomical study of the temporal bone, Locke et al 32 explained that one possible reason for the inconsistent results obtained with endolymphatic sac surgeries is that the sac itself is difficult to identify and a proper decompression is not often accomplished, much less a proper drainage. The reason for this is that the intradural component of the sac varies in size and position.
Discussion
The senior author has treated more than 90 patients with Mé niè re's disease with endolymphatic sac decompression since 1984, both in the National Institute of Neurology and Neurosurgery in Mexico City, and also in his private practice. Every patient complied with the criteria established at the 
time by the American Academy of Otolaryngology -Head and Neck Surgery (AAO-HNS). The method of endolymphatic sac decompression and drainage he employs is the same described by Portmann, and later modified by House. 7, 8, 10 It starts with a retroauricular C-shaped incision, as performed in retroauricular mastoid approaches, and a wide exposition of the mastoid cortex, a simple mastoidectomy and the proper identification of the posterior and lateral semicircular canals. The latter will serve as a landmark to identify the sac. After that, the bone that covers the sigmoid sinus and the posterior cranial fossa is thinned. Sometimes a small island of bone might be left covering the sigmoid sinus to prevent its damage, and by pressing it, the retrolabyrinthine area is better visualized. The sac is then identified between the posterior semicircular canal and the sigmoid sinus as a white and dense thickening of the dura. After properly identification of the sac, it is then carefully opened and drained. A Teflon (Hood Laboratories, Pembroke, USA) tube may or may not be used to obtain a permanent drainage into the subarachnoid space. Absorbable gelatin sponge saturated in a steroid and antibiotic solution is then placed in the mastoid cavity and the wound is closed in an ordinary fashion.
As we mentioned earlier, some authors have repeatedly suggested that the endolymphatic sac surgery is not more effective than a placebo. [4] [5] [6] Regardless of all uncertainties surrounding Mé niè re's disease treatment, and based on his experience, the senior author considers endolymphatic sac decompression and drainage as an excellent option to control vertiginous symptomatology and obtain auditory stabilization for medically refractory Mé niè re's disease with serviceable hearing. The meta-analysis by Sood et al 19 showed a vertigo control in the long term, after approximately 3 years of follow-up, of 81.6% of the patients for sac decompression alone compared to 75.7% for current mastoid shunt techniques. All in categories A and B according to the AAO-HNS classification representing total resolution and great improvement of vertigo respectively. 33 The results we have obtained are very similar.
As we mentioned earlier, a technique called endolymphatic duct blockage was described recently. patients that underwent endolymphatic sac decompression and drainage with a follow-up period that ranged from 3 to 15 years after surgery (average, 9 years), with 45 patients followed for a period longer than 10 years. In patients with unilateral disease, vertigo control was obtained in 94.3% of patients. A significant improvement in cochlear function was seen in 14% of patients, and hearing was preserved or improved in 88% of them. For the bilateral group, vertigo control was obtained in 85.7% of the patients and cochlear function improved in 28% of them. Hearing preservation was attained in 71% of these patients. It is important to mention that the natural history and progression of endolymphatic hydrops complicates the analysis of long-term surgical results since a large number of patients will ultimately stop having vertigo episodes by the time their posterior labyrinth is completely destroyed and their hearing is lost.
37

Final Comments
Endolymphatic sac surgery is still an excellent non-destructive surgical option for patients with incapacitating endolymphatic hydrops. It provides hearing preservation and a high percentage of vertigo control. Even though less surgeons indicate it these days on account of improvements in medical therapies and office-based procedures, it has important advantages over other forms of treatment for medically refractory Mé niè re's disease.
